sur Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025
Bausch Health Companies Inc. has announced the launch of Solta Medical's Fraxel FTX™, the next generation of skin resurfacing technology. Debuting at the American Society for Laser Medicine & Surgery 2025 Annual Conference, this latest advancement promises to enhance treatments in skin rejuvenation, targeting sun damage, wrinkles, acne scars, and pigmentation issues. Designed for precision, efficiency, and comfort, Fraxel FTX™ offers dermatologists and aesthetic professionals a cutting-edge tool to achieve noticeable results.
The Fraxel FTX™ system features a dual wavelength fractional laser for treating superficial and deep skin layers, a redesigned ergonomic handpiece, and an intelligent optical tracking system, promising minimal downtime for patients. Bausch Health aims to set a new standard in laser skin resurfacing, enhancing patient care and satisfaction. Plans are underway to expand the product's availability globally in the coming months.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bausch Health Companies Inc.